Methenamine hippurate - Urinary Tract Infection (UTIs)

You are here : Home > Formulary Search > Methenamine hippurate - Urinary Tract Infection (UTIs)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue

Formulations :

Tablets

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

BNF SPC

Restrictions / Comments :

Important

Prescribe on recommendation

Documentation

No records returned.

PAD Profile

ChemicalSubstance :

Methenamine hippurate

Indication :

Urinary Tract Infection (UTIs)

Group Name :

Keywords :

UTIs, recurrent UTIs, prophylactic antibiotics, UTI prophylaxis

Brand Names Include :

Important Information :

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Supporting Documents :

Other Indications

Below are listed other indications that Methenamine hippurate is used to treat.

No records returned.

Other Drugs

Below are listed other drugs that are used to treat Urinary Tract Infection (UTIs).

Pivmecillinam hydrochloride

Committee Recommendations (1)

06 Sep 23 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed methenamine hippurate as a prophylaxis and treatment option for recurrent UTIs in men and women.

Methenamine Hippurate will be given a BLUE (under specialist recommendation) for this indication.

This is an interim position and will be reviewed when NICE guidance on UTI prophylaxis is published.

The Antimicrobial Guidelines resources can be found here Guidelines : Antimicrobial guidelines - PAD Formulary (res-systems.net)